XAIR Beyond Air, Inc.
$3.20▲ +4.23%
Healthcare
Other
After hours
$3.28▲ +2.50%
Sep 11, 7:46 PM ET
Volume 63.4K
Avg Volume (10D) 1.09M
Key Metrics & Fundamentals
Market Cap
$3.15M
P/E Ratio
0.0
Div Yield
–%
52W Range
3.06 - 55.60
% vs 50 MA
-42.95%
% vs 200 MA
-76.66%
RSI-14
30.3
MACD Histogram
-0.1000
Beta (1Y vs SPY)
0.63
Free Cash Flow
-$5.15M
Gross Rev
$1.77M
Gross Profit
$225,000
EBITDA
-$5.68M
COGS
$1.54M
Operating Exp
$6.84M
Operating Income
-$6.61M
EBIT
-$6.61M
Pretax Income
-$8.15M
Net Income
-$7.94M
EPS (Diluted)
-220.00
Price & Volume History
Loading chart…
Recent News

Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference
GlobeNewswire · Sep 2, 2026 12:00 PM

Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
GlobeNewswire · Aug 31, 2026 12:00 PM

Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments
GlobeNewswire · Aug 25, 2026 11:00 AM

Beyond Air (XAIR) Q1 2027 Earnings Call Transcript
Motley Fool · Aug 14, 2026 3:58 AM
Beyond Air Inc (XAIR) (Q1 2027) Earnings Call Highlights: Strategic Financing and Pipeline ...
GuruFocus.com · Aug 13, 2026 11:09 PM

Beyond Air, Inc. Q1 2027 Earnings Call Summary
Moby · Aug 13, 2026 9:08 PM

Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
GlobeNewswire · Aug 13, 2026 11:00 AM
Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026
GlobeNewswire · Aug 4, 2026 12:00 PM
Beyond Air to Raise Up to $30.1 Million in Private Placement
MT Newswires · Jul 30, 2026 2:44 PM
Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire · Jul 30, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See XAIR's money flow as a full page
Social Sentiment
No Reddit posts found for XAIR.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.